© 1983 Oxford University Press
research-article |
Impairment in Pulmonary Bioenergetics Following Chlorphentermine Administration to Rats
AResearch Service, Veterans Administration Hospital and Department of Pharmacology, University of South Florida Medical Center Tampa, FL 33620 BDepartment of Pharmacology and Toxicology, West Virginia University Medical Center Morgantown, WV 26506
Impairment in Pulmonary Bioenergetics Following Chlorphentermine Administration to Rats. Zychlinski, Lech, Montgomery, Mark R., Shamblin, Patricia B., and Reasor, Mark J. (1983). Fundam. Appl. Toxicol. 3:192-198. Biochemical alteration in pulmonary oxidative metabolism and morphological integrity of lung mitochondria were examined in rats following administration of chlorphentermine (30 mg/kg, ip, 5 days per week) for 1 or 2 weeks. During the first week of treatment, body weight gain and food intake were decreased markedly but returned to control levels during the second week. Phospholipid content of the lung was increased 31% and 110% after 1 and 2 weeks of treatment, respectively. This was accompanied by a striking intraalveo-lar accumulation of hypertrophic alveolar macrophages. The metabolism of both (1-14C)- and (6-14C)-glucose was decreased 27% and 26%, respectively, after 2 weeks of drug treatment. In rat lung mitochondria, chlorphentermine significantly lowered the RCR and ADP/O ratio and stimulated state 4 respiration. State 3 respiration and uncoupled state respiration were unaffected. These data indicate that chlorphentermine functions as a true uncoupler of oxidative phosphorylation when administered in vivo. Furthermore, disruption of mitochondrial membranes was observed frequently in lung mitochondria from treated animals. These combined data indicate that the induction of pulmonary phospholipidosis by chlorphentermine is accompanied by marked alterations in subcellular bioenergetics and mito-chondrial structure.